Atlas Trials

Use Lay Language. HA Score to Identify Myeloma Patients Who Could Benefit From HDACi Treatment

Clinical trial NCT03515915 · UNKNOWN

Trial details

NCT number
NCT03515915
Sponsor
University Hospital, Montpellier
Status
UNKNOWN
Study type
OBSERVATIONAL
Patients With Recurrent or Refractory Multiple Myeloma
Start date
2018-04-23
Primary completion
2018-12-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.